11:49Is New Migraine Medicine on the Horizon?
From the creator
A new class of migraine drugs in late-stage development comes as scientists believe they may finally have unlocked some key biological mysteries about the debilitating condition. WSJ's Jonathan Rockoff joins Shelby Holliday to discuss. Photo: Corbis Subscribe to the WSJ channel here: http://bit.ly/14Q81Xy More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com Follow WSJ on Facebook: http://www.facebook.com/wsjvideo Follow WSJ on Google+: https://plus.google.com/+wsj/posts Follow WSJ on Twitter: https://twitter.com/WSJvideo Follow WSJ on Instagram: http://instagram.com/wsj Follow WSJ on Pinterest: http://www.pinterest.com/wsj/ Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com Visit the WSJ Video Center: https://wsj.com/video On Facebook: https://www.facebook.com/pg/wsj/videos/ On Twitter: https://twitter.com/WSJ On Snapchat: https://on.wsj.com/2ratjSM
Published 2016-03-21 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





